Berlin — On Tuesday, German health officials limit the use of AstraZeneca’s coronavirus vaccine to people under the age of 60 amid new concerns about abnormal blood clots reported in a small number of people who have been shot. I agreed.
Health Minister Jens Sparn and state officials belong to the high-risk category of serious illness due to COVID-19 and for people over the age of 60 unless they agree to vaccinate despite the low risk. It was unanimously agreed to vaccinate only. Serious side effects. The same option will be available to everyone who has taken a shot at the GP, which will be available later this month.
“In short, it’s about weighing the risk of side effects that are statistically small but need to be taken seriously against the risk of getting sick in the corona,” Spahn told reporters in Berlin.
The move, following the recommendation of an independent panel of German vaccine experts, in AstraZeneca’s recent recipients, has been reported by national medical regulators of abnormal forms of thrombosis in the head (known as sinus vein thrombosis). This will take place after the release of new data showing an increase in reported cases. vaccine.
The news is a further blow to vaccines, which is important for European vaccination campaigns and is the cornerstone of a global strategy to launch attacks on poorer countries. Less than two weeks after EU drug regulators said Vaccines do not increase the overall incidence of blood clots Following a similar horror.
The European Medicines Agency said at the time that the benefits of vaccination outweighed the risks, but the association between shots and some unusual types of blood clots cannot be ruled out and warns of possible rare side effects. Was recommended to add.
Several German regions, including the capital Berlin and the country’s most populous state, North Rhine-Westphalia, have so far reported about 2.7 million rare blood clots in Germany by March 29. A dose of AstraZeneca has been administered.
According to the Paul Erich Institute, nine people died and all but two were associated with women between the ages of 20 and 63.
In a statement prior to the announcement, AstraZeneca said tens of millions of people were vaccinated worldwide, and EU regulators and the World Health Organization concluded that the benefits of shots outweigh the risks. ..
The company works with German authorities to address questions while analyzing its records and reporting rare blood clots “more commonly than naturally expected in a population of millions.” Whether or not he understands. “”
Germany, along with other European countries, is struggling to strengthen its vaccine program, which is far behind the United Kingdom and the United States, and is imminently stopped. By Monday, approximately 13.2 million people in the country had been vaccinated at least once, and nearly 4 million had both vaccinated.
Use of the AstraZeneca vaccine was temporarily suspended in several European countries earlier this month due to concerns about rare blood clots. After a review by medical experts from the European Medicines Agency, most European Union countries, including Germany, Resumed use of vaccine March 19th.
on Monday, Canada has stopped using the AstraZeneca vaccine People under the age of 55 are quoting new things about data from Europe.
“Given the potential risks, there is considerable uncertainty about the benefits of providing the AstraZeneca COVID-19 vaccine to adults under the age of 55,” said Vice Member of the National Advisory Committee on Immunization in Canada. Dr. Sherry Dikes, the chief, said.
According to Dikes, the updated recommendation is that the risk of blood clots is now potentially high at 1 in 100,000, much higher than the previously believed risk of 1 in 1 million. It is said to be in the new data from Europe that suggests.
The German decision could affect the appointments of tens of thousands of teachers and people in existing conditions who were recently invited to be vaccinated in Berlin. Reservations for AstraZeneca Shots are now available earlier than those by Pfizer-BioNTech and Moderna. This is due to the high demand for these vaccines.
Scientists at the University of Greifswald in Germany released this week the results of an investigation into possible causes of blood clots. The condition is said to resemble the side effects seen in some patients taking the anticoagulant heparin.
This study, which has not yet been peer-reviewed, does not provide a definitive explanation for why some people vaccinated with AstraZeneca develop rare blood clots. Still, experts not involved in this study said it would provide important information to doctors.
Alice Asinger, an expert in vascular disease and blood clot research at the Medical University of Vienna, said there are treatments for rare blood clots.
However, others have warned that the German decision could harm the vaccine campaign.
“If people are not vaccinated, either because the use of the vaccine has been interrupted or because the decision has reduced confidence in the vaccine, some people will get sick with Covid-19. “The decision to withhold the vaccine will directly cause an excess and avoidable death of COVID-19,” said Peter English, a former chairman of the Medical Commission.
Spahn acknowledged that the decision to stop using vaccines under the age of 60 was a “definite retreat” of the vaccination campaign, and Germany will receive 15 million doses of AstraZeneca in the second quarter. I said there is.
But he said that the supply would be available to people over the age of 60 who would otherwise have had to wait longer, reducing the risk of getting a serious illness with COVID-19.
Initially, some European countries were hesitant to inject AstraZeneca into older people because of the lack of data from the company on the effectiveness of the vaccine in people over the age of 65. .. Subsequent studies showing that it works in older people have encouraged most countries to approve it for their age group.
German Chancellor Angela Merkel is likely to be the target of the shot soon.
The 66-year-old said Tuesday’s decision was important to ensure public confidence in the vaccine campaign and she would accept shots made by British and Swedish companies.
“When it’s my turn, I’ll allow vaccination, including AstraZeneca,” Merkel said.
Maria Cheng, AP Medical Writer in London, contributed to this report.
Follow the AP’s pandemic coverage at:
Germany restricts the use of AstraZeneca under the age of 60 over blood clots | News
Source link Germany restricts the use of AstraZeneca under the age of 60 over blood clots | News